Health Care & Life Sciences » Biotechnology | Vernalis PLC

Vernalis PLC

Vernalis PLC
Stock Exchange Other OTC
EPS
 -
Market Cap
 -
Shares Outstanding
 526.99 M
Public Float
 -
Vernalis PLC
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 526.99 M
Public Float
 -
Vernalis PLC
Stock Exchange London Stock Exchange
EPS
 GBP0.09
Market Cap
 GBP32.36 M
Shares Outstanding
 526.99 M
Public Float
 524.09 M

Profile

Address
100 Berkshire Place
Winnersh Berkshire RG41 5RD
United Kingdom
Employees -
Website http://vernalis.com
Updated 09/14/2018
Vernalis Plc is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U. S.

Financials

View All

Peter John Fellner
Non-Executive Chairman
Ian Garland
Chief Executive Officer & Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.